% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Pickel:893930,
author = {Pickel, Simone and Cruz-Garcia, Yiliam and Bandleon, Sandra
and Barkovits, Katalin and Heindl, Cornelia and Völker,
Katharina and Abeßer, Marco and Pfeiffer, Kathy and Schaaf,
Alice and Marcus, Katrin and Eder-Negrin, Petra and Kuhn,
Michaela and Miranda Laferte, Erick},
title = {{T}he β$_{2}$-{S}ubunit of {V}oltage-{G}ated {C}alcium
{C}hannels {R}egulates {C}ardiomyocyte {H}ypertrophy},
journal = {Frontiers in Cardiovascular Medicine},
volume = {8},
issn = {2297-055X},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {FZJ-2021-02940},
pages = {704657},
year = {2021},
abstract = {L-type voltage-gated calcium channels (LTCCs) regulate
crucial physiological processes in the heart. They are
composed of the Cavα1 pore-forming subunit and the
accessory subunits Cavβ, Cavα2δ, and Cavγ. Cavβ is a
cytosolic protein that regulates channel trafficking and
activity, but it also exerts other LTCC-independent
functions. Cardiac hypertrophy, a relevant risk factor for
the development of congestive heart failure, depends on the
activation of calcium-dependent pro-hypertrophic signaling
cascades. Here, by using shRNA-mediated Cavβ silencing, we
demonstrate that Cavβ2 downregulation enhances
α1-adrenergic receptor agonist-induced cardiomyocyte
hypertrophy. We report that a pool of Cavβ2 is targeted to
the nucleus in cardiomyocytes and that the expression of
this nuclear fraction decreases during in vitro and in vivo
induction of cardiac hypertrophy. Moreover, the
overexpression of nucleus-targeted Cavβ2 in cardiomyocytes
inhibits in vitro-induced hypertrophy. Quantitative
proteomic analyses showed that Cavβ2 knockdown leads to
changes in the expression of diverse myocyte proteins,
including reduction of calpastatin, an endogenous inhibitor
of the calcium-dependent protease calpain. Accordingly,
Cavβ2-downregulated cardiomyocytes had a 2-fold increase in
calpain activity as compared to control cells. Furthermore,
inhibition of calpain activity in Cavβ2-downregulated cells
abolished the enhanced α1-adrenergic receptor
agonist-induced hypertrophy observed in these cells. Our
findings indicate that in cardiomyocytes, a nuclear pool of
Cavβ2 participates in cellular functions that are
independent of LTCC activity. They also indicate that a
downregulation of nuclear Cavβ2 during cardiomyocyte
hypertrophy promotes the activation of calpain-dependent
hypertrophic pathways.},
cin = {IBI-1},
ddc = {610},
cid = {I:(DE-Juel1)IBI-1-20200312},
pnm = {5243 - Information Processing in Distributed Systems
(POF4-524)},
pid = {G:(DE-HGF)POF4-5243},
typ = {PUB:(DE-HGF)16},
pubmed = {34307509},
UT = {WOS:000674908500001},
doi = {10.3389/fcvm.2021.704657},
url = {https://juser.fz-juelich.de/record/893930},
}